Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...
Among adults with acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA) with planned ...
As India’s cold chain market targets double-digit growth through 2028, the $5 billion quick-commerce boom is forcing a ...
New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCyCompany announced first patients dosed in the Phase 2 ...
The Space Force pressed ahead with R-GPS using the funding it had, even after Congress declined to approve the additional $77 million. A year later, the dynamic has reversed: the Space Force says it ...
Germany should build as many nuclear plants as possible, Fatih Birol proclaims.
Nanterre, 5 February 2026 OUTSTANDING PERFORMANCE - RECORD FREE CASH FLOW Revenue growth: €74.6 billion (+4%) - operating earnings up for each of the Group's three businesses: Concessions, Energy Solu ...
Readers of a certain age may remember BMW releasing the i3 mini EV way back in 2013. It's a chic-looking electric hatchback ...
Northumberland Gazette on MSN
Cramlington-based engineering firm accelerates global growth
A Cramlington-based engineering firm is entering a new phase of expansion after achieving three consecutive years of more ...
Q4 2025 earnings call recap: record EBITDA/EPS, 2026 revenue growth outlook, tariff/EPA27 risks, Accelera reset—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results